Ligand Pharmaceuticals reported $15.49M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Amgen USD 6.58B 146M Jun/2025
Arrowhead Research USD -173085000 173.08M Dec/2024
Baxter International USD 2.17B 124M Mar/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
Glaxosmithkline 6.07B 403M Jun/2025
Insmed USD 107.6M 6.89M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Ligand Pharmaceuticals USD 15.49M 875K Jun/2025
MacroGenics USD 9.28M 9.28M Jun/2025
Merck USD 6.6B 405M Jun/2025
Pacira USD 148.16M 14.41M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Veracyte USD 25.02M 766K Jun/2025